A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022

NCT05791695 · clinicaltrials.gov ↗

COMPLETED

Status

155413

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Inflammation
Suspected Endophthalmitis

Interventions

OTHER: Non Applicable

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]